AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25738177 — intervention group
Group type: EXPERIMENTAL
Intervention: Short maxillary implants
Number of subjects: 60
Study 25738177 — intervention group
Group type: EXPERIMENTAL
Intervention: Long maxillary implants
Number of subjects: 60
Study 25738177 — intervention group
Group type: COMPARATOR
Intervention: Comparison of short vs long implants
Number of subjects: 60
Study 25302575 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index energy reduced (LGI-ER) diet
Number of subjects: 90
Study 25302575 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index energy reduced (HGI-ER) diet
Number of subjects: 90
Study 25302575 — intervention group
Group type: COMPARATOR
Intervention: No energy restriction, GI provision, or nutritional counseling (Control)
Number of subjects: 90
Study 21975148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training intervention for 5 weeks
Number of subjects: 32
Study 21975148 — intervention group
Group type: COMPARATOR
Intervention: Usual activity (control) for 5 weeks
Number of subjects: 32
Study 19608438 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stocking for 4 weeks
Number of subjects: 104
Study 19608438 — intervention group
Group type: COMPARATOR
Intervention: No compression stocking
Number of subjects: 104
Study 17445287 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant withdrawal
Number of subjects: 0
Study 17445287 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine withdrawal
Number of subjects: 0
Study 15910687 — intervention group
Group type: EXPERIMENTAL
Intervention: Heberitro (formulation A)
Number of subjects: 34
Study 15910687 — intervention group
Group type: COMPARATOR
Intervention: Eprex (formulation B)
Number of subjects: 34
Study 15910687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 34
Study 14612287 — intervention group
Group type: EXPERIMENTAL
Intervention: Special group (imaging changes based on ultrasonography and CT)
Number of subjects: 204
Study 14612287 — intervention group
Group type: COMPARATOR
Intervention: Routine group (based on blood and urine amylase levels, gastrointestinal function, symptoms)
Number of subjects: 204
Study 14612287 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 204
Study 9885587 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture-site-dependent recumbent position (210 biopsies)
Number of subjects: 390
Study 9885587 — intervention group
Group type: COMPARATOR
Intervention: Puncture-site-nondependent recumbent position (213 biopsies)
Number of subjects: 390
Study 7495686 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluene‐350 tissue solubilizer
Number of subjects: 0
Study 15235998 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% or 0.5% bupivacaine at a rate of 3‐7 ml.hr(‐1)
Number of subjects: 120
Study 15235998 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% morphine at a rate of 1‐2 ml.hr(‐1)
Number of subjects: 120
Study 15235998 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.125% or 0.25% bupivacaine and 0.0025% or 0.005% morphine at a rate of 2‐4 ml.hr(‐1)
Number of subjects: 120
Study 401348 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 401348 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone
Number of subjects: 0
Study 401348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30614881 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared fluorescent cholangiography (NIFC)
Number of subjects: 639
Study 30614881 — intervention group
Group type: COMPARATOR
Intervention: White light (WL)
Number of subjects: 639
Study 28135219 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) program for 6 weeks
Number of subjects: 23
Study 28135219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study 28358452 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg isobaric levobupivacaine
Number of subjects: 30
Study 28358452 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg isobaric bupivacaine
Number of subjects: 30
Study 23610207 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated, humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 432
Study 23610207 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 432
Study 21136268 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia (IA)
Number of subjects: 167
Study 21136268 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (SA)
Number of subjects: 167
Study 21136268 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA)
Number of subjects: 167
Study 21136268 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 167
Study 19782792 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited exercise testing
Number of subjects: 2331
Study 19782792 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 2331
Study 18192203 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 25
Study 18192203 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 25
Study 18192203 — intervention group
Group type: COMPARATOR
Intervention: Twelve-step Facilitation (TSF)
Number of subjects: 25
Study 15176527 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials in surgery
Number of subjects: 0
Study 15176527 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study 11335691 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetization Transfer Imaging (MTI)
Number of subjects: 55
Study 11335691 — intervention group
Group type: COMPARATOR
Intervention: Control (age‐matched controls)
Number of subjects: 55
Study 9535992 — intervention group
Group type: EXPERIMENTAL
Intervention: EM574 5 mg
Number of subjects: 30
Study 9535992 — intervention group
Group type: EXPERIMENTAL
Intervention: EM574 10 mg
Number of subjects: 30
Study 9535992 — intervention group
Group type: EXPERIMENTAL
Intervention: EM574 20 mg
Number of subjects: 30
Study 9535992 — intervention group
Group type: EXPERIMENTAL
Intervention: EM574 30 mg
Number of subjects: 30
Study 9535992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8042481 — intervention group
Group type: EXPERIMENTAL
Intervention: Single nail (Rydell)
Number of subjects: 410
Study 8042481 — intervention group
Group type: COMPARATOR
Intervention: 2 LIH hook pins (LIH)
Number of subjects: 410
Study 3189965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) 2 grams administered IV for 20 minutes (0.40 mmol/min)
Number of subjects: 10
Study 3189965 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) administered IV for 20 minutes
Number of subjects: 10
Study 15800308 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine (AM) 500 mg IV four times per week
Number of subjects: 243
Study 15800308 — intervention group
Group type: COMPARATOR
Intervention: No Amifostine (no AM)
Number of subjects: 243
Study 30548504 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 58
Study 28663062 — intervention group
Group type: EXPERIMENTAL
Intervention: ProFiL training-and-communication network program
Number of subjects: 442
Study 28663062 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 442
Study 25673037 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-defined interventions
Number of subjects: 69
Study 25673037 — intervention group
Group type: COMPARATOR
Intervention: Infliximab intensification
Number of subjects: 69
Study 23746047 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar TURP
Number of subjects: 186
Study 23746047 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 186
Study 23746047 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 186
Study 23746047 — intervention group
Group type: COMPARATOR
Intervention: All groups (Monopolar TURP, Bipolar TURP, PVP)
Number of subjects: 186
Study 22185086 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive two-year long physical activity intervention during school hours
Number of subjects: 320
Study 22185086 — intervention group
Group type: COMPARATOR
Intervention: General curriculum-based physical activity (control)
Number of subjects: 320
Study 19951514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral rSO2 measurement using NIRS in normal full-term neonates
Number of subjects: 420
Study 19951514 — intervention group
Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement using NIRS in neonates with diseases
Number of subjects: 420
Study 19951514 — intervention group
Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement in cases with severe cerebral damages
Number of subjects: 420
Study 19951514 — intervention group
Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement during recovery of critically ill neonates
Number of subjects: 420
Study 19951514 — intervention group
Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement during severe phases of serious hypoxic-ischemic encephalopathy (HIE)
Number of subjects: 420
Study 17087311 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treatment with folic acid, vitamin B12, and B6
Number of subjects: 0
Study 17087311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin treatment for reduction of hyperhomocysteinemia
Number of subjects: 0
Study 17087311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin treatment
Number of subjects: 0
Study 12544649 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol hyperhydration (1.0 g.kg(-1))
Number of subjects: 11
Study 12544649 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol rehydration (0.5 g.kg(-1))
Number of subjects: 11
Study 12544649 — intervention group
Group type: COMPARATOR
Intervention: Placebo hyperhydration
Number of subjects: 11
Study 12544649 — intervention group
Group type: COMPARATOR
Intervention: Placebo rehydration
Number of subjects: 11
Study 12544649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Glycerol and Placebo
Number of subjects: 11
Study 10963922 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Brief Intervention (IBI); Participants received a brief one-to-one clinical assessment interview and self-help materials.
Number of subjects: 61
Study 10963922 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Brief Intervention (IBI); Follow-up interviews at 1 and 3 months.
Number of subjects: 61
Study 9709312 — intervention group
Group type: EXPERIMENTAL
Intervention: Combitube (Combi)
Number of subjects: 470
Study 9709312 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal Tracheal Lumen Airway (PTL)
Number of subjects: 470
Study 9709312 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask (LM)
Number of subjects: 470
Study 9709312 — intervention group
Group type: COMPARATOR
Intervention: Oral airway/Bag-Valve-Mask (OA/BVM) system
Number of subjects: 470
Study 9709312 — intervention group
Group type: EXPERIMENTAL
Intervention: PTL, LM, and Combi
Number of subjects: 470
Study 9709312 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective evaluation
Number of subjects: 470
Study 8369231 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ)
Number of subjects: 20
Study 8369231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3521541 — intervention group
Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 50
Study 3521541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 50
Study 29776899 — intervention group
Group type: EXPERIMENTAL
Intervention: Group exercise intervention using videoconferencing and mobile apps (e.g., Nike+, Sworkit) for 8 weeks.
Number of subjects: 64
Study 29776899 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control with access to recommended mobile apps and invitation to join exercise group after 8 weeks.
Number of subjects: 64
Study 28183816 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 28
Study 28183816 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 28
Study 28183816 — intervention group
Group type: COMPARATOR
Intervention: Both HIIT and MICT
Number of subjects: 28
Study 26156733 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU ergocalciferol/wk for 12 weeks
Number of subjects: 90
Study 26156733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 23369067 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus craniosacral therapy
Number of subjects: 123
Study 23369067 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 123
Study 20386484 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast cadence (FC) = 1-second descent/1-second ascent
Number of subjects: 6
Study 20386484 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium cadence (MC) = 3-second descent/1-second ascent
Number of subjects: 6
Study 20386484 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow cadence (SC) = 4-second descent/2-second ascent
Number of subjects: 6
Study 20298304 — intervention group
Group type: EXPERIMENTAL
Intervention: EIB test protocol (8-min treadmill run without warming up, workload at 95% of maximum heart rate)
Number of subjects: 40
Study 20298304 — intervention group
Group type: COMPARATOR
Intervention: Stepwise protocol (common stepwise protocol with 20 min warming up)
Number of subjects: 40
Study 16641225 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) during manipulation tasks
Number of subjects: 0
Study 16641225 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) during maintenance tasks
Number of subjects: 0
Study 12895137 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritalin LA 20mg
Number of subjects: 36
Study 10632125 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexedrine (10 mg)
Number of subjects: 0
Study 10632125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8602776 — intervention group
Group type: EXPERIMENTAL
Intervention: Krypton red laser photocoagulation treatment for classic CNV
Number of subjects: 0
Study 8602776 — intervention group
Group type: EXPERIMENTAL
Intervention: Krypton red laser photocoagulation treatment for classic and occult CNV
Number of subjects: 0
Study 8602776 — intervention group
Group type: COMPARATOR
Intervention: No treatment for eyes with occult CNV but no classic CNV
Number of subjects: 0
Study 1384762 — intervention group
Group type: EXPERIMENTAL
Intervention: GIK group (glucose, 0.6 g/kg/h; insulin, 0.12 U/kg/h; KCl, 0.12 mmol/kg/h)
Number of subjects: 32
Study 1384762 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate (R group)
Number of subjects: 32
Study 2579598 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 50 mg t.i.d., 48 h prior to and up to 24 h following challenge with anti-IgE 1/3300 (v/v)
Number of subjects: 27
Study 2579598 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 250 mg, b.i.d.
Number of subjects: 27
Study 2579598 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 75 micrograms (i.d.)
Number of subjects: 27
Study 2579598 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (oral and i.d.)
Number of subjects: 27
Study 31866595 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) approach with household enumeration
Number of subjects: 972
Study 31866595 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) administering surveys and spirometry
Number of subjects: 972
Study 31866595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling method using hollows as units
Number of subjects: 972
Study 28624167 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide Implant
Number of subjects: 255
Study 28624167 — intervention group
Group type: COMPARATOR
Intervention: Systemic Corticosteroid Therapy
Number of subjects: 255
Study 28624167 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide Implant (for individuals with initial visual acuity worse than 20/40)
Number of subjects: 255
Study 25822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based training
Number of subjects: 163
Study 25822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced learning
Number of subjects: 163
Study 25822326 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person training
Number of subjects: 163
Study 25822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost training activities
Number of subjects: 163
Study 24406570 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1
Number of subjects: 15
Study 24406570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 22450889 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0
Study 19410094 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 5
Study 19410094 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Branco
Number of subjects: 5
Study 19410094 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA BIO
Number of subjects: 5
Study 19410094 — intervention group
Group type: EXPERIMENTAL
Intervention: white Portland cement + 20% bismuth oxide (PC1)
Number of subjects: 5
Study 19410094 — intervention group
Group type: EXPERIMENTAL
Intervention: white Portland cement + 10% calcium chloride (PC2)
Number of subjects: 5
Study 17123297 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical first stage lead placement (FSLP)
Number of subjects: 30
Study 17123297 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous needle electrode (PNE)
Number of subjects: 30
Study 17123297 — intervention group
Group type: EXPERIMENTAL
Intervention: FSLP
Number of subjects: 30
Study 17123297 — intervention group
Group type: EXPERIMENTAL
Intervention: FSLP and PNE responders
Number of subjects: 30
Study 16377603 — intervention group
Group type: COMPARATOR
Intervention: Single, untailored smoking cessation guide (SU)
Number of subjects: 1978
Study 16377603 — intervention group
Group type: EXPERIMENTAL
Intervention: Single, tailored smoking cessation guide (ST)
Number of subjects: 1978
Study 16377603 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple tailored printed materials (MT)
Number of subjects: 1978
Study 16377603 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple tailored printed materials with interim data (MRT)
Number of subjects: 1978
Study 16377603 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple message group conditions (MT + MRT)
Number of subjects: 1978
Study 16377603 — intervention group
Group type: EXPERIMENTAL
Intervention: MRT materials
Number of subjects: 1978
Study 16563599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase (TNK)
Number of subjects: 50
Study 16563599 — intervention group
Group type: COMPARATOR
Intervention: Standard ACLS measures
Number of subjects: 50
Study 10565450 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes mellitus (IDDM) patients
Number of subjects: 22
Study 10565450 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 8727452 — intervention group
Group type: EXPERIMENTAL
Intervention: MedX lumbar‐extension machine, isotonic exercises two times per week, reduced to one time per week, average length of treatment 97 days and 20 visits.
Number of subjects: 0
Study 8727452 — intervention group
Group type: COMPARATOR
Intervention: Healthy asymptomatic geriatric females (HEAL)
Number of subjects: 0
Study 1364779 — intervention group
Group type: EXPERIMENTAL
Intervention: MR tomography
Number of subjects: 64
Study 6405908 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term outpatient treatment programme of eclectic orientation
Number of subjects: 30
Study 30797646 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate reduced hospital diet (CRD) of 135 g/d
Number of subjects: 62
Study 30797646 — intervention group
Group type: COMPARATOR
Intervention: Non-carbohydrate reduced hospital diet (NCRD)
Number of subjects: 62
Study 28614953 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-Air Warming (FAW)
Number of subjects: 127
Study 28614953 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 127
Study 27161546 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan 60 mg
Number of subjects: 290
Study 27161546 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan 120 mg
Number of subjects: 290
Study 27161546 — intervention group
Group type: COMPARATOR
Intervention: Candesartan 8 mg
Number of subjects: 290
Study 25238424 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium:Yttrium aluminum garnet (YAG) laser delivery system (LDS) used for transmyocardial revascularization (TMR)
Number of subjects: 42
Study 22213153 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzastaurin (loading dose 1125 mg, followed by 500 mg/d) with 5-fluorouracil/leucovorin plus bevacizumab
Number of subjects: 117
Study 22213153 — intervention group
Group type: COMPARATOR
Intervention: Placebo with 5-fluorouracil/leucovorin plus bevacizumab
Number of subjects: 117
Study 22213153 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzastaurin
Number of subjects: 117
Study 22213153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 19959339 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate
Number of subjects: 312
Study 19959339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 19959339 — intervention group
Group type: COMPARATOR
Intervention: Paliperidone palmitate and Placebo
Number of subjects: 312
Study 18306904 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (16 mg/die for the first 7 days, then 8 mg die for another 7 days, and finally 4 mg die for another 7 days) plus conventional therapy (bronchodilators and inhaled corticosteroids)
Number of subjects: 28
Study 18306904 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional therapy only)
Number of subjects: 28
Study 15677559 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA and idarubicin induction followed by 3 polychemotherapy consolidation courses
Number of subjects: 124